WM
White Marvin L
Chairman & CEO
C-suiteM
Insider track record
CEONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by White Marvin L, Chairman & CEO. Officer active across 2 companies, notably Emergent BioSolutions Inc.. Aggregated, 16 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €160k. History available since 20 May 2021. The latest transaction was filed on 6 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to White Marvin L
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
1 sharesCommon StockSEC:0001193125-26-343070:0
1,666 sharesCommon StockSEC:0001193125-26-343070:1
406 shares@ US$4.07Common StockSEC:0001193125-26-343070:2
10 sharesCommon StockSEC:0000950170-25-097269:0
34,403 shares0Common StockSEC:0001367644-25-000110:0
8 sharesCommon StockSEC:0000950170-25-032187:0
14,287 shares@ US$11.97100.0% of flowCommon StockSEC:0001367644-24-000184:0
17,430 shares0Common StockSEC:0001367644-24-000086:0
12,917 sharesCommon StockSEC:0000950170-24-025878:0
4,792 sharesCommon StockSEC:0000950170-24-009002:0
33,847 shares0Common StockSEC:0001367644-23-000109:0
9,582 sharesCommon StockSEC:0001209191-23-016774:0
4,791 sharesCommon StockSEC:0001209191-23-005423:0
8,446 shares0Common StockSEC:0001367644-22-000091:0
4,792 sharesCommon StockSEC:0001019056-22-000114:0
5,027 shares0Common StockSEC:0001367644-21-000087:0
About White Marvin L
White Marvin L is Président-Directeur Général, Administrateur. He is linked to Aptevo Therapeutics Inc. and Emergent BioSolutions Inc. The 13 filings cover the period from 2021-05-24 to 2025-07-21; within the sampled recent filings, total sell volume is EUR 159605 and the most common transaction nature is Levée d'options.